Medtronic To Face Class Action Suit From Canadian Users Of MiniMed Insulin Pumps - Medtronic (NYSE:MDT)

A national class action in Canada has been commenced against Medtronic Plc MDT over its MiniMed 630G and 670G insulin pumps.
Rochon Genova and Cardill Law commenced the proposed class-action suit against Medtronic, Medtronic MiniMed, and Medtronic of Canada over the insulin pumps approved in Canada in 2016 and 2018.
Related Link: Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps.
For the same issue, missing or broken retainer rings that could result in the over-or under-delivery of insulin, Health Canada issued a Type II Medical Device Recall in 2019, then a Type 1 recall earlier this month.
The proposed class action alleges that Medtronic knew or ought to have known that the devices were suffering from a defective retainer ring but failed to take steps to address it or offer warnings to users.
The claims have not yet been proven in court.
Medtronic did not directly comment on the class action suit but referred to its October 5 news release covering the issue with the MiniMed 600 series devices.
Price Action: MDT shares are down 1.07% at $121.19 during the market session on the last check Thursday.